TrianglePUBLICATIONS · 17264331
Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2007 Feb 1
- First author
- Pappo AS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Pappo AS
- type
- Author
- name
- Lyden E
- type
- Author
- name
- Breitfeld P
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Wiener E
- type
- Author
- name
- Parham D
- type
- Author
- name
- Crews KR
- type
- Author
- name
- Houghton P
- type
- Author
- name
- Meyer WH
- type
- Author
- name
- Children's Oncology Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Pappo AS
- type
- Author
- name
- Lyden E
- type
- Author
- name
- Breitfeld P
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Wiener E
- type
- Author
- name
- Parham D
- type
- Author
- name
- Crews KR
- type
- Author
- name
- Houghton P
- type
- Author
- name
- Meyer WH
- type
- Author
- name
- Children's Oncology Group
- type
- CollectiveName
- bibliography ids
- nci-bib-059e07adffe69863546b1389
- book metadata
- content sha256
- 2c39b916c4a8b44eeb8686f9378a41e9ccf2822f8429712423c5f5cb0046129a
- document type
- citation
- dois
- 10.1200/JCO.2006.07.1720
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17264331
- immutable id
- pubmed:17264331@2c39b916c4a8b44eeb8686f9378a41e9ccf2822f8429712423c5f5cb0046129a
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 4
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 362-9
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17264331
- provenance
- batch id
- e687ecc838c318f9ec65
- provider
- NCBI PubMed ESummary
- record sha256
- 99ccd7ff1c30ffce9a9261c6737210592799b1cccf85f3376432be9fc6477a49
- response sha256
- 57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
- retrieved at
- 2026-09-09T23:46:11.674833+00:00
- publication date
- display
- 2007 Feb 1
- precision
- day
- year
- 2007
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
Preserved source evidence · Not medical advice